Registration deadline extended to 09 December 2015

The NC3Rs, Innovate UK and the Knowledge Transfer Network are jointly hosting a workshop to advance the development and application of bioprinting approaches for improved efficacy and safety testing of drugs and other chemicals.

The workshop is being organised as part of the Non-Animal Technologies programme to accelerate the uptake of novel technologies that have the potential to transform business and improve product development across a range of industries. Bringing together scientists from across sectors and disciplines the meeting will:

• Highlight capabilities and opportunities in bioprinting in the UK;
• Highlight end-user needs and potential applications for bioprinting;
• Connect potential end-users with bioprinting technology developers to encourage collaboration in model development;
• Define opportunities for future NATs funding.

Programme

The programme consists of presentations, posters and networking opportunities. Speakers from academia and industry will cover current capabilities in bioprinting approaches, gaps and opportunities for development, and potential new applications in a range of industries. Confirmed speakers include:

• Professor Brian Derby, University of Manchester
• Dr Joel Segal, University of Nottingham
• Dr Lorna Ewart, AstraZeneca
• Dr Andy Scott, Unilever
• Dr Colin Wilde, AvantiCell Science Ltd.
• Dr Gary Allenby, Aurelia Bioscience
• Dr Mike Sullivan, Innovate UK
• Dr Jos Malda, University Medical Center Utrecht
• Dr Alex Charlton, Syngenta
• Dr Will Shu, Renishaw plc/Clyde Biosciences/Heriot-Watt University Consortium

The draft agenda can be found here.

Posters

Delegates are encouraged to submit poster abstracts on a topic relevant to the theme of the meeting. Selected abstracts will be chosen for presentation during the capability showcase. To present a poster, please complete the abstract submission form and submit by 09 November 2015. We will let you know if you have been selected for oral presentation by 13 November 2015. 

Who should attend

Scientists from across academia, industry, and the SME sector who are:

• Developing bioprinting approaches (for example, bioinks, scaffold technologies, extrusion methods, etc);
• Keen to translate bioprinting approaches to new markets and applications;
• Seeking to adopt bioprinting approaches as new models/tools for improving safety and efficacy testing, and understanding of human and animal health and disease.

Registration

Attendance is free but advanced registration is essential. Registration closes on 09 December 2015. 

You will need an NC3Rs website account to register. Please use your institutional email address when registering.